IR Live
On-demand
-
Tuesday, May 17, 2022 · 2:00 PM CESTCopenhagen, Denmark, 6 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) invites to a presentation of the results from the clinical trial of FG001 used to guide surgery in patients with aggressive high-grade glioma brain cancer, which will f... -
Monday, March 14, 2022 · 11:00 AM CETThe company's management will present the outcome of the directed issue announced on March 10:
Copenhagen, Denmark, 17:31 CEST, 10 March 2022 – FluoGuide A/S (publ), a developer of surgical precision solutions within oncology (“FluoGuide” or the ... -
-
Monday, October 11, 2021 · 9:30 AM CESTFG001 is proven safe in patients undergoing surgery for cancer – a significant milestone for FluoGuide to further advance clinical development in aggressive brain cancer and in a prevalent indication.
This investor call will allow investors to l...
Past
-
-
-
Evergreen WebinarBased on the publication of the Interim Report earlier the same day, the senior Management Team will offer a walkthrough of the report contents and answer questions from the audience.
The Example Company does not really exist and is only made up ...
